IPCA Laboratories- 2QFY19 Results – Growing While Awaiting USFDA Approvals
Ipca Laboratories (IPCA IN) 2QFY19 PAT of Rs 1,197 mn beat our estimates of Rs 1,023 mn. EBITDA margins, excluding forex loss, stood at 20.4%,...
567 Views
IPCA Labs: 1QFY19 Result - International Sales Decline but EBITDA Margins Improve
Ipca Laboratories (IPCA IN) reported revenue growth of 20% YoY at Rs. 8,427 mn, EBITDA at Rs. 1,140 mn and PAT at Rs. 655 mn in 1QFY19 led by low...
397 Views
IPCA: Annual Report FY18: Normal Service to Resume
Ipca Laboratories (IPCA IN)'s FY18 revenue grew ~2.5% YoY to Rs. 32,587 mn. EBITDA stood at Rs. 4,812 mn (6.3% YoY growth), with the margins of...
604 Views
IPCA 4QFY18 Results Confirm Recovery Story
Performance Highlights IPCA Labs reported 4QFY18 revenue at Rs. 7,828 mn as against our expectation of Rs 7,666 mn. EBITDA stood at Rs. 1,099 mn,...
182 Views
IPCA Labs- The Revival Story
Ipca Laboratories Ltd (IPCA IN) is a fully integrated Indian pharmaceutical company. In FY17 45% of its revenues came from Indian dosage business,...
476 Views